-
Science Saturday: Link between preterm labor, fetal DNA supported by cell culture research
Share this:
If the average TV show is to be believed, going into labor is easy to predict. It will happen to any character who is pregnant at the worst or most inconvenient time.
In in real life, how labor begins is a mystery — and not necessarily a good one. Babies born before 37 weeks of pregnancy are called "preterm" and have a higher risk of death or persistent health problems than babies born at term. Preterm birth affects one in 10 infants born in the U.S., according to the Centers for Disease Control and Prevention.
"This gap in the knowledge of what causes labor to begin has devastating consequences," says Elizabeth Ann Enninga, Ph.D., a Mayo Clinic immunologist. "If we don't know what initiates labor, we can’t stop it when it starts too soon."
Researchers think the mother's immune system is key because it has been implicated in other aspects of the labor process. Dr. Enninga and her team started with the interaction between the fetus and the mother's body. A fetus’ placenta releases DNA during pregnancy, which begins circulating in the mother's bloodstream. This cell-free fetal DNA is collected early in pregnancy to screen for genetic abnormalities and sex.
Read the rest of the article on the Discovery's Edge blog.
____________________________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Advancing the Science
- Mayo Clinic Laboratories
- Forefront
- Center for Individualized Medicine
- Center for Regenerative Medicine
- Center for the Science of Health Care Delivery
Share this:
Related articles
To glimpse the future of medicine, step inside Mayo Clinic's cutting-edge Center for Individualized Medicine. There, physicians, researchers, data scientists, artificial intelligence engineers and bioethicists are ...
Mayo Clinic physician-scientists are working on regenerative biotherapeutics such as orthobiologics and other regenerative bioinjectables to bring advanced procedures to more patients. Orthobiologics are biological agents ...
In 2018, a male patient in his 60s began experiencing chest pains, which turned out to be caused by multiple blood clots in his lungs. ...